eHealth (EHTH)
(Delayed Data from NSDQ)
$4.55 USD
-0.02 (-0.33%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $4.53 -0.02 (-0.44%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.55 USD
-0.02 (-0.33%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $4.53 -0.02 (-0.44%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Zacks News
eHealth (EHTH) Q4 Earnings Miss on Higher Operating Costs
by Zacks Equity Research
eHealth (EHTH) expects revenues to be in the range of $450-$475 million in 2024.
EHealth (EHTH) Misses Q4 Earnings Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -17.01% and 1.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Exploring the Driving Forces Behind eHealth's (EHTH) Q4 Earnings
by Zacks Equity Research
eHealth's (EHTH) fourth-quarter 2023 results are likely to reflect higher expenses and Individual, Family and Small Business segment revenues.
eHealth (EHTH) Surges 20.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
eHealth (EHTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Aon (AON) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of 4.04% and 2.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 8.21% and 4.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Hold Strategy is Apt for eHealth (EHTH) Stock Now
by Zacks Equity Research
eHealth's (EHTH) transformation initiatives are lowering its costs and expanding margins.
eHealth (EHTH) Soars 13.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
eHealth (EHTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
eHealth (EHTH) Revises 2023 Guidance: Here's What We Think
by Zacks Equity Research
eHealth (EHTH) anticipates its adjusted EBITDA for 2023 to be within a loss of $3 million and a profit of $17 million, which shows significant improvement from the previous guidance.
EHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -10.53% and 33.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 7.14% and 2.17%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Q2 Earnings Lag Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of -13.87% and 1.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Why You Should Consider Buying Brown & Brown (BRO) Stock
by Zacks Equity Research
New businesses, better customer retention, premium-rate increases across the majority of business lines, strategic acquisitions and a strong financial position poise Brown & Brown (BRO) for growth.
eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).
eHealth (EHTH) Targets 8-10% Adjusted EBITDA Margin by 2025
by Zacks Equity Research
By the trailing 12-month period ending March 2025, eHealth (EHTH) expects to enter the positive operating cash flow region.
EHealth (EHTH) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -21.52% and 20.35%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 13.04% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 1.07% and 2.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Brown & Brown (BRO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 3.70% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Marsh & McLennan (MMC) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 3.27% and 1.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Arthur J. Gallagher (AJG) Closes Buck Buyout, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher (AJG) bought partnership interest in BCHR Holdings, L.P., dba Buck and its subsidiaries for $660 million to consolidate its portfolio of professional services.
Brown & Brown (BRO) Boosts Canada Presence With HBG Buyout
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Highcourt Partners is likely to provide it solid opportunities and a robust leadership team to boost growth in Canada.
Is Euronet Worldwide (EEFT) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Euronet Worldwide (EEFT) and eHealth (EHTH) have performed compared to their sector so far this year.
eHealth (EHTH) Q4 Earnings Top, Approved Members Fall Y/Y
by Zacks Equity Research
eHealth (EHTH) Q4 results reflect lower operating costs and expenses. However, revenues declined and so did approved members.
EHealth (EHTH) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 147.83% and 12.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?